Our Services
RxCelerate offers complex in vitro translational studies using relevant patient samples. This service bridges preclinical findings to real human biology to help de-risk clinical development.
Our integrated team combines scientific, clinical, and operational expertise to deliver high-value, human-relevant data that informs key development decisions.
We provide full end-to-end study delivery, from ethical approval and targeted volunteer recruitment to sample collection and storage at our HTA-approved site and in-house analysis.
Better, more relevant data
With ~90% of drugs failing in clinical trials, de-risking development early is critical to improving success rates. We help generate disease-relevant data earlier in development to help build asset value.
IMPROVE DECISION-MAKING & REDUCE LATE-STAGE FAILURES
Confirm mechanism of action of your drug candidates in cells or samples from volunteers with disease-relevant biology.
USE IN PRECISION MEDICINE
Use biomarker identification studies to define target population more accurately, reduce the size of future studies and improve efficacy readouts.
FASTER CLINICAL TRIAL
DESIGN & EXECUTION
Develop an understanding of baseline data, improve your understanding of population variance and generate more accurate power calculations.
Case Study – Crohn’s Disease
RxCelerate supported a virtual biotech developing novel small molecule therapies for Crohn’s disease, providing fully integrated services spanning in silico discovery, medicinal chemistry, in vitro screening, in vivo PK and efficacy.
By integrating scientific, clinical, and operational expertise within a single team, RxCelerate delivered high-value, human-relevant data that informed key development decisions.
This case study details how we designed and delivered a complex in vitro human translational study, demonstrating how our unique translational capabilities can accelerate progress and de-risk early-stage programmes for our clients.
RxCelerate offers a unique business model catering to both small molecules and biologics. We work with you to drive your asset through drug discovery, preclinical research and beyond.
Our combination of integrated teams and unique technologies allows RxCelerate to develop the optimal drug discovery strategy to deliver pharma-grade drug candidates quickly and at a fraction of the cost of traditional approaches.